BIOMAT Database Logo BIOMAT Database Logo

Synthesis of 3-phenylpyrazolopyrimidine-1,2,3-triazole conjugates and evaluation of their Src kinase inhibitory and anticancer activities. 2011

Anil Kumar, and Israr Ahmad, and Bhupender S Chhikara, and Rakesh Tiwari, and Deendayal Mandal, and Keykavous Parang
Department of Chemistry, Birla Institute of Technology and Science, Pilani, Rajasthan, India.

A series of two classes of 3-phenylpyrazolopyrimidine-1,2,3-triazole conjugates were synthesized using click chemistry approach. All compounds were evaluated for inhibition of Src kinase and human ovarian adenocarcinoma (SK-Ov-3), breast carcinoma (MDA-MB-361), and colon adenocarcinoma (HT-29). Hexyl triazolyl-substituted 3-phenylpyrazolopyrimidine exhibited inhibition of Src kinase with an IC(50) value of 5.6 μM. 4-Methoxyphenyl triazolyl-substituted 3-phenylpyrazolopyrimidine inhibited the cell proliferation of HT-29 and SK-Ov-3 by 73% and 58%, respectively, at a concentration of 50 μM.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D011714 Pyrans Pyran
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole

Related Publications

Anil Kumar, and Israr Ahmad, and Bhupender S Chhikara, and Rakesh Tiwari, and Deendayal Mandal, and Keykavous Parang
Synthesis of 1,4-disubstituted 1,2,3-triazole Derivatives Using Click Chemistry and their Src Kinase Activities.
January 2016, Medicinal chemistry (Shariqah (United Arab Emirates)),
Anil Kumar, and Israr Ahmad, and Bhupender S Chhikara, and Rakesh Tiwari, and Deendayal Mandal, and Keykavous Parang
3-substitued indoles: one-pot synthesis and evaluation of anticancer and Src kinase inhibitory activities.
June 2011, Bioorganic & medicinal chemistry letters,
Anil Kumar, and Israr Ahmad, and Bhupender S Chhikara, and Rakesh Tiwari, and Deendayal Mandal, and Keykavous Parang
Synthesis of 1,2,3-Triazole Derivatives and Evaluation of their Anticancer Activity.
January 2013, Scientia pharmaceutica,
Anil Kumar, and Israr Ahmad, and Bhupender S Chhikara, and Rakesh Tiwari, and Deendayal Mandal, and Keykavous Parang
Phthalazone tethered 1,2,3-triazole conjugates: In silico molecular docking studies, synthesis, in vitro antiproliferative, and kinase inhibitory activities.
April 2023, Bioorganic chemistry,
Anil Kumar, and Israr Ahmad, and Bhupender S Chhikara, and Rakesh Tiwari, and Deendayal Mandal, and Keykavous Parang
Semi-Synthesis of New 1,2,3-Triazole Derivatives of 9-Bromonoscapine and their Anticancer Activities.
January 2021, Iranian journal of pharmaceutical research : IJPR,
Anil Kumar, and Israr Ahmad, and Bhupender S Chhikara, and Rakesh Tiwari, and Deendayal Mandal, and Keykavous Parang
4-Aryl-4H-chromene-3-carbonitrile derivatives: evaluation of Src kinase inhibitory and anticancer activities.
September 2011, Medicinal chemistry (Shariqah (United Arab Emirates)),
Anil Kumar, and Israr Ahmad, and Bhupender S Chhikara, and Rakesh Tiwari, and Deendayal Mandal, and Keykavous Parang
Design, synthesis and anticancer activity of matrine-1H-1,2,3-triazole-chalcone conjugates.
June 2015, Bioorganic & medicinal chemistry letters,
Anil Kumar, and Israr Ahmad, and Bhupender S Chhikara, and Rakesh Tiwari, and Deendayal Mandal, and Keykavous Parang
1,2,3-Triazole-nimesulide hybrid: Their design, synthesis and evaluation as potential anticancer agents.
February 2017, Bioorganic & medicinal chemistry letters,
Anil Kumar, and Israr Ahmad, and Bhupender S Chhikara, and Rakesh Tiwari, and Deendayal Mandal, and Keykavous Parang
Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
January 2020, Current topics in medicinal chemistry,
Anil Kumar, and Israr Ahmad, and Bhupender S Chhikara, and Rakesh Tiwari, and Deendayal Mandal, and Keykavous Parang
Piperazine-1,2,3-triazole scaffolds: design, synthesis, anticancer and antimicrobial evaluation.
April 2023, Future medicinal chemistry,
Copied contents to your clipboard!